Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 15Lymphoma, Non-Hodgkin 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Mantle-Cell 8Lymphoma, Follicular 8Lymphoma, B-Cell 7Lymphoma 7Hodgkin Disease 6Burkitt Lymphoma 6Lymphoma, B-Cell, Marginal Zone 4Waldenstrom Macroglobulinemia 3Multiple Myeloma 3Lymphoma, Large-Cell, Anaplastic 3Leukemia 3Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Extranodal NK-T-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Immunoblastic Lymphadenopathy 2Recurrence 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 75fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 59Mycophenolic Acid 53Tacrolimus 51Whole-Body Irradiation 48Busulfan 42Antilymphocyte Serum 40Cyclosporine 38Filgrastim 32fludarabine 31Methotrexate 30Melphalan 29Radiotherapy 22Methylprednisolone 18Cord Blood Stem Cell Transplantation 17Etoposide 16Sirolimus 14Alemtuzumab 13Flow Cytometry 12Cyclosporins 12thymoglobulin 11Granulocyte Colony-Stimulating Factor 11Cytarabine 10Psychiatric Rehabilitation 9sargramostim 8Thiotepa 8Rituximab 8Therapeutics 7Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × Leukapheresis × Lymphoid × Clear all
NCT02639559 2023-11-07

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Washington University School of Medicine

Phase 2 Completed
50 enrolled 23 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01413568 2016-02-26

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Polyphor Ltd.

Phase 1/2 Completed
38 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡